UPDATE: BofA Securities Downgrades Ultragenyx Pharma (RARE) to Neutral

November 12, 2020 4:18 AM EST Send to a Friend
(Updated - November 12, 2020 7:48 AM EST)

(updated to add analyst comments)BofA Securities analyst Tazeen Ahmad downgraded ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login